Navigation Links
Biogenics Research Chamber Announces Facility Extension
Date:5/9/2013

San Antonio, Texas (PRWEB) May 09, 2013

Biogenics Research Chamber (http://www.biogenicschamber.com), a unique allergy testing facility in San Antonio, Texas, has broken ground on an extension. The 5,400 square feet will house a large allergy exposure chamber, a specialty chamber, and eye examination rooms. The chambers will utilize clean room technology with complete electrical back-up by generator. The extension will enhance capacity for simultaneous testing of large numbers of participants, while broadening therapeutic testing capabilities.

Dr. Robert Jacobs, founder and co-owner, noted that “It is amazing to think that we have outgrown our existing chambers in just three short years. We are excited to be the U.S. leaders in this area of research.”

Biogenics Research Chamber, the only large permanent pollen exposure chamber in the United States, opened in 2010 in the Medical Center of San Antonio. Projects have included pharmaceutical and vaccine trials and scientific studies elucidating the basic mechanisms and genetics of allergy. The extension, scheduled for completion in January 2014, is engineered to challenge with seasonal pollens as well as year-round allergy-provoking agents including dust mites and cat dander. The specialty chamber is designed for testing of novel agents for non-allergic eye and respiratory conditions.

About the Company:
Dr. Robert L. Jacobs, Dr. Daniel A. Ramirez and Dr. Charles P. Andrews are the owners and Principal Investigators of the Biogenics Research Chamber located in San Antonio, Texas. The facility has challenge chambers designed to conduct allergic and non-allergic exposure studies in a controlled environment that utilizes clean room technology. Proof of concept, dose-ranging, and onset of action studies are performed for pharmaceutical and vaccine trials. For companies investigating new products, the chambers offer the advantage of concentrating resources with the potential to shorten medication and vaccine development times.
                                                                    ###

Read the full story at http://www.prweb.com/releases/2013/5/prweb10697751.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. GeneTex Introduces New Mouse Monoclonal Antibody Against the Ten-Eleven Translocation 1 (TET1) Protein for DNA Methylation/Epigenetics Research
2. Core Facility Management Software Company Builds API to Extend Complex Workflows in Research
3. The Alliance for the Advancement of Adult Stem Cell Therapy and Research Recently Has Proven Stem Cells To Be Effective in Dilated Cardiomyopathy
4. Cell Culture Market is Expected to Reach USD 16.85 Billion Globally in 2018: Transparency Market Research
5. Peripheral Vascular Devices Market is Expected to Reach USD 7.8 Billion Globally in 2018: Transparency Market Research
6. Real Time Genomics and J. Craig Venter Institute Embark on Strategic Research Initiative
7. David Hooper Joins Evolution Marketing Research as Senior Director, Research
8. Averica Discovery Services and Worcester Polytechnic Institute Establish Research Collaboration
9. Heptares Achieves All Research Milestones and Receives Milestone Payment From GPCR Drug Discovery Agreement With Takeda
10. Society for Women’s Health Research IMAGINES IT -- SWHR’s Annual Gala Imagines the Future: Information Technology (IT) Transforms Women’s Healthcare
11. Altogen Labs Offers New Pre-Clinical CRO Services to Accelerate Pre-Clinical Research Needs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... 2017 , ... A new study published in Fertility and ... in vitro fertilization (IVF) transfer cycles. The multi-center matched cohort study ... comparing the results from the fresh and frozen transfer cohorts, the authors of ...
(Date:10/10/2017)... California (PRWEB) , ... October 10, 2017 , ... Dr. ... speaking at his local San Diego Rotary Club. The event entitled ... Diego, CA and had 300+ attendees. Dr. Harman, DVM, MPVM was joined by ...
(Date:10/9/2017)... 2017  BioTech Holdings announced today identification and ... ProCell stem cell therapy prevents limb loss in ... demonstrated that treatment with ProCell resulted in more ... compared to standard bone marrow stem cell administration.  ... reduction of therapeutic effect.  ...
(Date:10/7/2017)... ... October 06, 2017 , ... ... consulting for microscopy and surface analysis, Nanoscience Instruments is now expanding into ... a broad range of contract analysis services for advanced applications. Services will ...
Breaking Biology Technology:
(Date:4/13/2017)... India , April 13, 2017 According to ... Proofing, Identity Authentication, Identity Analytics, Identity Administration, and Authorization), Service, Authentication Type, ... MarketsandMarkets™, the IAM Market is expected to grow from USD 14.30 Billion ... Growth Rate (CAGR) of 17.3%. ... MarketsandMarkets ...
(Date:4/11/2017)... Research and Markets has announced the addition of the ... ... grow at a CAGR of 30.37% during the period 2017-2021. ... prepared based on an in-depth market analysis with inputs from industry ... over the coming years. The report also includes a discussion of ...
(Date:4/11/2017)... NXT-ID, Inc. (NASDAQ:   NXTD ) ... appointment of independent Directors Mr. Robin D. Richards ... Directors, furthering the company,s corporate governance and expertise. ... Gino Pereira , Chief Executive ... their guidance and benefiting from their considerable expertise as we ...
Breaking Biology News(10 mins):